Chen Wang (IMAGE)
Caption
Use of Chen Wang's optical coherence tomography probe could lead to fewer failed kidney cancer biopsies.
Credit
University of Oklahoma
Usage Restrictions
N/A
License
Original content
Use of Chen Wang's optical coherence tomography probe could lead to fewer failed kidney cancer biopsies.
University of Oklahoma
N/A
Original content